BCR-ABL1 p230(μbcr) Detection Kit
£1,274.00
The BCR-ABL1 p230(μbcr) Detection Kit leverages advanced one-step RT-qPCR technology for the fast and accurate detection of the BCR-ABL1 p230 fusion gene, commonly associated with chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL). Offering superior analytical sensitivity (log4 reduction) and accurate relative quantitation through multiplex PCR, this CE-IVD certified kit is compatible with FAM and VIC/HEX dual-color real-time PCR instruments, facilitating a streamlined diagnostic process for leukemia, a malignant condition characterized by the overproduction of abnormal white blood cells in the bone marrow.
The BCR-ABL1 p230(μbcr) Detection Kit leverages advanced one-step RT-qPCR technology for the fast and accurate detection of the BCR-ABL1 p230 fusion gene, commonly associated with chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL). Offering superior analytical sensitivity (log4 reduction) and accurate relative quantitation through multiplex PCR, this CE-IVD certified kit is compatible with FAM and VIC/HEX dual-color real-time PCR instruments, facilitating a streamlined diagnostic process for leukemia, a malignant condition characterized by the overproduction of abnormal white blood cells in the bone marrow.
- Superior Analytical Sensitivity: Achieves a log4 reduction, ensuring high sensitivity in detecting low levels of the BCR-ABL1 p230 fusion transcript.
- One Step RT-qPCR Technology: Simplifies the detection process, making it both fast and user-friendly.
- Multiplex PCR: Enables accurate relative quantitation by comparing fusion transcripts to ABL1 gene expression.
- Instrument Compatibility: Designed for use with FAM and VIC/HEX dual-color real-time PCR instruments, broadening its utility in various laboratory settings.
- CE-IVD Certification: Meets European standards for in vitro diagnostic medical devices, affirming the kit’s reliability and quality.
- Efficient Diagnosis: Streamlines the detection of the BCR-ABL1 p230 fusion gene, crucial for diagnosing and monitoring specific types of leukemia.
- High Sensitivity and Accuracy: Ensures reliable detection and quantitation of the BCR-ABL1 fusion gene, even at low levels, facilitating early diagnosis and treatment.
- Ease of Use: The one-step RT-qPCR approach reduces complexity and time required for testing, making it accessible for routine diagnostic use.
Leukemia Diagnosis and Monitoring: Specifically designed for the detection of the BCR-ABL1 p230 fusion gene in patients suspected of having chronic myelogenous leukemia (CML) or acute lymphoblastic leukemia (ALL), aiding in diagnosis and treatment monitoring.
- Technology: Utilizes one-step RT-qPCR with multiplex PCR for the detection and relative quantitation of the BCR-ABL1 p230 fusion transcript.
- Sensitivity: Superior analytical sensitivity (log4 reduction) for detecting low levels of the target gene.
- Compatibility: Compatible with FAM and VIC/HEX dual-color real-time PCR instruments.
- Certification: CE-IVD marked, indicating compliance with EU regulations for in vitro diagnostic use.
Why Choose Clent
We strive to enable our customers to focus on the results of their work, rather than the tools they use. Need to speak with a member of our team? Get in touch today.
